NCT04362644View on ClinicalTrials.gov

Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis

PHASE1RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 8, 2020

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG

PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714

Study participants will undergo PET/CT with the glucose analogue \[F-18\]FDG and the translocator protein (TSPO) ligand \[F-18\]DPA-714 in two separate imaging sessions.

Trial Locations (1)

35249

RECRUITING

The University of Alabama at Birmingham, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER